It has been clearly established that sexually transmitted human papillomavirus (HPV)
infections are the major cause of genital warts and cervical cancer and are a contributing …

Objective. This study's purpose was to assess knowledge and concerns related to the
human papillomavirus (HPV) vaccine among underserved Latina women and Latina …

Background. A reduction in the incidence of genital warts (GWs) is one of the first markers of
the effectiveness of vaccination against human papillomavirus (HPV) at the population level …

Background The objective of this study was to estimate the number of years after onset of a
quadrivalent HPV vaccination program before notable reductions in genital warts and …

OBJECTIVES: To review concepts, information, obstacles, and approaches to cervical
cancer screening and prevention as vaccination against human papillomavirus (HPV) types …

Background Assessing the impact and effectiveness of HPV vaccines on anogenital warts in
the United States can provide early indication of the success of vaccination programs as well …

Recently published data from large efficacy studies suggest that human papillomavirus
(HPV) vaccines can substantially reduce anogenital neoplasia and warts overall when …

Background: Administration of the human papillomavirus (HPV) vaccine is recommended for
adolescent girls and young adult women. Little is known about the factors associated with …

Objective We estimated the prevalence of human papillomavirus (HPV) vaccination by
ethnicity and race and compared vaccination use by known risk factors. Materials and …

Last year, the World Health Organization (WHO) convened a gathering of experts, including
scientists, national regulatory authorities, industry representatives, epidemiologists and …